Inicio › Carcinoma de células escamosas de cabeza y cuello › Pensilvania
Ensayos clínicos de Carcinoma de células escamosas de cabeza y cuello en Pensilvania
41 estudios sobre Carcinoma de células escamosas de cabeza y cuello buscan participantes en Pensilvania.
Ciudades en Pensilvania
Texto oficial del estudio (inglés)
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
- Geisinger Medical Center, Danville
- Geisinger Cancer Center Dickson City, Dickson City
- UPMC Hillman Cancer Center Erie, Erie
- y 21 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06992427FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
- Site #0103, Pittsburgh
- Site #0123, Pittsburgh
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06788990Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #104, Hershey
- Exelixis Clinical Site #98, Philadelphia
- Exelixis Clinical Site #32, Pittsburgh
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT05176483Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Carlisle Regional Cancer Center, Carlisle
- y 15 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06589804A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, Pittsburgh
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT05877599A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
- Penn State Milton S. Hershey Medical Center, Hershey
- University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07276399Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
- UPMC Hillman Cancer Center, Pittsburgh
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06980038BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Thomas Jefferson University Hospital, Philadelphia
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT05136196JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
- University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia
ReclutandoFase 3
Edades de 60 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT04892173A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
- University of Pennsylvania, Philadelphia
ReclutandoFase 1
Edades de 18 a 74 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07219212Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- UPMC Altoona, Altoona
- Geisinger Medical Center, Danville
- UPMC Hillman Cancer Center Erie, Erie
- y 12 más
ReclutandoFase 2
Edades de 18 a 79 · Todos los sexos · Actualizado el 22 sept 2026 · NCT04671667ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of Pennsylvania, Philadelphia
- WellSpan Medical Oncology & Hematology at York Cancer Center, York
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT05059444Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- Lehigh Valley Hospital-Cedar Crest, Allentown
- UPMC Altoona, Altoona
- UPMC-Heritage Valley Health System Beaver, Beaver
- y 27 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT02734537Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Research Site, Philadelphia
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 sept 2026 · NCT06535607A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- University of Pennsylvania, Philadelphia
- Cancer Care Associates of York, York
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT06163534Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
- UPMC Hillman Cancer Center, Pittsburgh
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT07156227FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT07216105A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Asplundh Cancer Pavilion, Willow Grove
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 ago 2026 · NCT06769698A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Research Site, Pittsburgh
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 ago 2026 · NCT07115043A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Philadelphia
- Normunity Investigational Site, Philadelphia
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT07182149Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- Carlisle Regional Cancer Center, Carlisle
- Geisinger Medical Center, Danville
- UPMC Hillman Cancer Center Erie, Erie
- y 9 más
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT04333537Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- Chambersburg Hospital, Chambersburg
- Ephrata Cancer Center, Ephrata
- UPMC Hillman Cancer Center Erie, Erie
- y 16 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
- Christiana Care Health System-Concord Health Center, Chadds Ford
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT07441681A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- University of Pennsylvania, Philadelphia
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 jul 2026 · NCT03526835Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
- UPMC Hillman Cancer Center, Pittsburgh
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 jun 2026 · NCT04114136Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- Perelman Center for Advanced Medicine /ID# 250188, Philadelphia
- UPMC Hillman Cancer Ctr /ID# 225706, Pittsburgh
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 jun 2026 · NCT04777994A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Pittsburgh
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 may 2026 · NCT06256588Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery
- Abramson Cancer Center at University of Pennsylvania, Philadelphia
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 may 2026 · NCT06747390Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas
- Fox Chase Cancer Center, Philadelphia
- Temple University Hospital, Philadelphia
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 abr 2026 · NCT07455032Window of Opportunity in Preserving Laryngeal Function Trial
- UPMC Hillman Cancer, Pittsburgh
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 abr 2026 · NCT07423078A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- Fox Chase Cancer Center, Philadelphia
- University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 abr 2026 · NCT06064877A Study of VET3-TGI in Patients With Solid Tumors
- UPMC- Hillman Cancer Center, Pittsburgh
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 abr 2026 · NCT06444815Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- University of Pennsylvania, Philadelphia
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 feb 2026 · NCT07030257Virtual Reality 3D-Surgery Modeling to Enhance Head and Neck Cancer Surgery Quality
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 feb 2026 · NCT05031910A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 feb 2026 · NCT06778863Use of SPY Imaging System to Minimize Fistulas After Hypopharyngeal Reconstruction
- UPMC, Pittsburgh
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 ene 2026 · NCT06831149VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Cancer Care Associates of York (site 206), York
ReclutandoFase 1/2
Edades de 18 a 80 · Todos los sexos · Actualizado el 11 dic 2025 · NCT03556228A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 oct 2025 · NCT06699212A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
- University of Pittsburgh Medical Center, Pittsburgh
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 oct 2025 · NCT04370587Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- UPMC Hillman Cancer Center, Pittsburgh
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 ago 2025 · NCT04429542De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.